| 000 | 01777 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250515100454.0 | ||
| 264 | 0 | _c20080528 | |
| 008 | 200805s 0 0 eng d | ||
| 022 | _a1590-8658 | ||
| 024 | 7 |
_a10.1016/j.dld.2007.10.013 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _ade Boer, N K H | |
| 245 | 0 | 0 |
_aAbsence of nodular regenerative hyperplasia after low-dose 6-thioguanine maintenance therapy in inflammatory bowel disease patients. _h[electronic resource] |
| 260 |
_bDigestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver _cFeb 2008 |
||
| 300 |
_a108-13 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Multicenter Study | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntimetabolites, Antineoplastic _xadverse effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aHyperplasia |
| 650 | 0 | 4 |
_aInflammatory Bowel Diseases _xdrug therapy |
| 650 | 0 | 4 |
_aLiver _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aThioguanine _xadministration & dosage |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aZondervan, P E | |
| 700 | 1 | _aGilissen, L P L | |
| 700 | 1 | _aden Hartog, G | |
| 700 | 1 | _aWesterveld, B D | |
| 700 | 1 | _aDerijks, L J J | |
| 700 | 1 | _aBloemena, E | |
| 700 | 1 | _aEngels, L G J B | |
| 700 | 1 | _avan Bodegraven, A A | |
| 700 | 1 | _aMulder, C J J | |
| 773 | 0 |
_tDigestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver _gvol. 40 _gno. 2 _gp. 108-13 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.dld.2007.10.013 _zAvailable from publisher's website |
| 999 |
_c17596097 _d17596097 |
||